medical

Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may reduce the risk of Alzheimer's disease, a new study published Thursday finds.
What is Prop 35? Look at CA measure focused on healthcare insurance
Harris' doctor reports VP in 'excellent health'
Twins born conjoined celebrate 1st birthday after separation surgery
Some people are overdosing on semaglutide, FDA warns
Pfizer targets obesity with new once-daily Danuglipron drug
Teens on Medi-Cal can get mental health service without parent consent
More Stories
Bloomberg Philanthropies gifting $1 billion to medical school
Biden administration to ban medical debt from credit reports
1st fatal human case of bird flu subtype confirmed in Mexico: WHO
What to know about infections from DIY press-on nails
Neuralink's first brain implant patient shares story
What to know about self-swabbing for HPV after FDA approves new kits
New Wegovy clinical trial finds surprising benefits beyond weight loss
Chinese Hospital in San Francisco celebrates 125th anniversary
CHSU College of Osteopathic Medicine earns seven-year Accreditation
Black patients benefit from new kidney evaluation
Drug shortages hit record-high, hundreds in short supply: Pharmacists
Fresno State unveils mobile health units to help expand care in Valley
Show More
Show Fewer
More Stories
What is Prop 35? Look at CA measure focused on healthcare insurance
Harris' doctor reports VP in 'excellent health'
Twins born conjoined celebrate 1st birthday after separation surgery
Some people are overdosing on semaglutide, FDA warns
Pfizer targets obesity with new once-daily Danuglipron drug
Teens on Medi-Cal can get mental health service without parent consent
Bloomberg Philanthropies gifting $1 billion to medical school
Biden administration to ban medical debt from credit reports
1st fatal human case of bird flu subtype confirmed in Mexico: WHO
What to know about infections from DIY press-on nails
Neuralink's first brain implant patient shares story
What to know about self-swabbing for HPV after FDA approves new kits
New Wegovy clinical trial finds surprising benefits beyond weight loss
Chinese Hospital in San Francisco celebrates 125th anniversary
CHSU College of Osteopathic Medicine earns seven-year Accreditation
Black patients benefit from new kidney evaluation
Drug shortages hit record-high, hundreds in short supply: Pharmacists
Fresno State unveils mobile health units to help expand care in Valley
Show More
Show Fewer